{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:14:31Z","timestamp":1767845671727,"version":"3.49.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1093\/humrep\/14.12.2963","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:22:29Z","timestamp":1027722149000},"page":"2963-2968","source":"Crossref","is-referenced-by-count":74,"title":["Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea"],"prefix":"10.1093","volume":"14","author":[{"given":"I.R.","family":"Pirwany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.S.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.T.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,12]]},"reference":[{"key":"key\n\t\t\t\t20170410032420_ACBAY-AND-GUNDOGDU-1996","unstructured":"Acbay, O. and Gundogdu, S. (1996) Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil. Steril., 65, 946\u2013949."},{"key":"key\n\t\t\t\t20170410032420_ADAMS-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Adams, J., Polson, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. Clin. Res. Ed., 293, 355\u2013359.","DOI":"10.1136\/bmj.293.6543.355"},{"key":"key\n\t\t\t\t20170410032420_BARBIERI-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Barbieri, R.L., Makris, A., Randall, R.W. et al. (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab., 62, 904\u2013910.","DOI":"10.1210\/jcem-62-5-904"},{"key":"key\n\t\t\t\t20170410032420_BARBIERI-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Barbieri, R.L., Smith, S. and Ryan, K.J. (1988) The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril., 50, 197\u2013212.","DOI":"10.1016\/S0015-0282(16)60060-2"},{"key":"key\n\t\t\t\t20170410032420_BERGH-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Bergh, C., Carlsson, B., Olsson, J.H. et al. (1993) Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil. Steril., 59, 323\u2013331.","DOI":"10.1016\/S0015-0282(16)55675-1"},{"key":"key\n\t\t\t\t20170410032420_CARA-AND-ROSENFIELD-1988","doi-asserted-by":"crossref","unstructured":"Cara, J.F. and Rosenfield, R.L. (1988) Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology, 123, 733\u2013739.","DOI":"10.1210\/endo-123-2-733"},{"key":"key\n\t\t\t\t20170410032420_CHANG-ETAL-1983","doi-asserted-by":"crossref","unstructured":"Chang, R.J., Nakamura, R.M., Judd, H.L. et al. (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356\u2013359.","DOI":"10.1210\/jcem-57-2-356"},{"key":"key\n\t\t\t\t20170410032420_CIGOLINI-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Cigolini, M., Seidell, J.C., Charzewska, J. et al. (1991) Fasting serum insulin in relation to fat distribution, serum lipid profile, and blood pressure in European women: the European Fat Distribution Study. Metab. Clin. Exp., 40, 781\u2013787.","DOI":"10.1016\/0026-0495(91)90003-F"},{"key":"key\n\t\t\t\t20170410032420_CRAVE-ETAL-1995","unstructured":"Crave, J.C., Fimbel, S., Lejeune, H. et al. (1995) Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J. Clin. Endocrinol. Metab., 80, 2057\u20132062."},{"key":"key\n\t\t\t\t20170410032420_DEVANE-ETAL-1975","doi-asserted-by":"crossref","unstructured":"DeVane, G.W., Czekala, N.M., Judd, H.L. et al. (1975) Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am. J. Obstet. Gynecol., 121, 496\u2013500.","DOI":"10.1016\/0002-9378(75)90081-2"},{"key":"key\n\t\t\t\t20170410032420_DUNAIF-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Dunaif, A., Segal, K.R., Futterweit, W. et al. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165\u20131174.","DOI":"10.2337\/diab.38.9.1165"},{"key":"key\n\t\t\t\t20170410032420_DUNAIF-ETAL-1996","unstructured":"Dunaif, A., Scott, D., Finegood, D. et al. (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 3299\u20133306."},{"key":"key\n\t\t\t\t20170410032420_EDWARDS-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Edwards, K.L., Austin, M.A., Newman, B. et al. (1994) Multivariate analysis of the insulin resistance syndrome in women. Arterioscler. Thromb., 14, 1940\u20131945.","DOI":"10.1161\/01.ATV.14.12.1940"},{"key":"key\n\t\t\t\t20170410032420_EHRMANN-ETAL-1997A","doi-asserted-by":"crossref","unstructured":"Ehrmann, D.A., Schneider, D.J., Sobel, B.E. et al. (1997a) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 2108\u20132116.","DOI":"10.1210\/jc.82.7.2108"},{"key":"key\n\t\t\t\t20170410032420_EHRMANN-ETAL-1997B","doi-asserted-by":"crossref","unstructured":"Ehrmann, D.A., Cavaghan, M.K., Imperial, J. et al. (1997b) Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 82, 524\u2013530.","DOI":"10.1210\/jc.82.2.524"},{"key":"key\n\t\t\t\t20170410032420_FRANKS-1995","doi-asserted-by":"crossref","unstructured":"Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med., 333, 853\u2013861.","DOI":"10.1056\/NEJM199509283331307"},{"key":"key\n\t\t\t\t20170410032420_FRANKS-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Franks, S., Gharani, N., Waterworth, D. et al. (1997) The genetic basis of polycystic ovary syndrome. Hum. Reprod., 12, 2641\u20132648.","DOI":"10.1093\/humrep\/12.12.2641"},{"key":"key\n\t\t\t\t20170410032420_GILLING-SMITH-ETAL-1994","unstructured":"Gilling-Smith, C., Willis, D.S., Beard, R.W. et al. (1994) Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J. Clin. Endocrinol. Metab., 79, 1158\u20131165."},{"key":"key\n\t\t\t\t20170410032420_GILLING-SMITH-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Gilling-Smith, C., Story, H., Rogers, V. et al. (1997) Evidence for a primary abnormality of thecal cell steroidogenesis in polycystic ovary syndrome. Clin. Endocrinol., 47, 93\u201399.","DOI":"10.1046\/j.1365-2265.1997.2321049.x"},{"key":"key\n\t\t\t\t20170410032420_KIDDY-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Kiddy, D.S., Hamilton-Fairley, D., Bush, A. et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol., 36, 105\u2013111.","DOI":"10.1111\/j.1365-2265.1992.tb02909.x"},{"key":"key\n\t\t\t\t20170410032420_KYEI-MENSAH-ETAL-1998","unstructured":"Kyei-Mensah, A.A., LinTan, S., Zaidi, J. et al. (1998) Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum. Reprod., 13, 1437\u20131441."},{"key":"key\n\t\t\t\t20170410032420_MORIN-PAPUNEN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Morin-Papunen, L.C., Koivunen, R.M., Ruokonen, A. et al. (1998) Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil. Steril., 69, 691\u2013696.","DOI":"10.1016\/S0015-0282(98)00011-9"},{"key":"key\n\t\t\t\t20170410032420_NAHUM-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Nahum, R., Thong, K.J., and Hillier, S.G. (1995) Metabolic regulation of androgen production by human thecal cells in vitro. Hum. Reprod., 10, 75\u201381.","DOI":"10.1093\/humrep\/10.1.75"},{"key":"key\n\t\t\t\t20170410032420_NESTLER-AND-JAKUBOWICZ-1996","doi-asserted-by":"crossref","unstructured":"Nestler, J.E. and Jakubowicz, D.J. (1996) Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N. Engl. J. Med., 335, 617\u2013623.","DOI":"10.1056\/NEJM199608293350902"},{"key":"key\n\t\t\t\t20170410032420_NESTLER-ETAL-1989","doi-asserted-by":"crossref","unstructured":"Nestler, J.E., Barlascini, C.O., Matt, D.W. et al. (1989) Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 68, 1027\u20131032.","DOI":"10.1210\/jcem-68-6-1027"},{"key":"key\n\t\t\t\t20170410032420_NESTLER-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Nestler, J.E., Jakubowicz, D.J., Evans, W.S. et al. (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N. Engl. J. Med., 338, 1876\u20131880.","DOI":"10.1056\/NEJM199806253382603"},{"key":"key\n\t\t\t\t20170410032420_PASQUALI-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Pasquali, R., Casimiri, F., Cantobelli, S. et al. (1993) Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm. Res., 39, 179\u2013187.","DOI":"10.1159\/000182732"},{"key":"key\n\t\t\t\t20170410032420_PORETSKY-AND-KALIN-1987","doi-asserted-by":"crossref","unstructured":"Poretsky, L. and Kalin, M.F. (1987) The gonadotropic function of insulin. Endocr. Rev., 8, 132\u2013141.","DOI":"10.1210\/edrv-8-2-132"},{"key":"key\n\t\t\t\t20170410032420_REBAR-ETAL-1976","doi-asserted-by":"crossref","unstructured":"Rebar, R., Judd, H.L., Yen, S.S. et al. (1976) Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest., 57, 1320\u20131329.","DOI":"10.1172\/JCI108400"},{"key":"key\n\t\t\t\t20170410032420_ROBINSON-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Robinson, S., Rodin, D.A., Deacon, A. et al. (1992) Which hormone tests for the diagnosis of polycystic ovary syndrome? Br. J. Obstet. Gynaecol., 99, 232\u2013238.","DOI":"10.1111\/j.1471-0528.1992.tb14505.x"},{"key":"key\n\t\t\t\t20170410032420_SCHOEMAKER-1991","doi-asserted-by":"crossref","unstructured":"Schoemaker, J. (1991) Neuroendocrine control in polycystic ovary-like syndrome. Gynecol. Endocrinol., 5, 277\u2013288.","DOI":"10.3109\/09513599109028449"},{"key":"key\n\t\t\t\t20170410032420_VELAZQUEZ-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Velazquez, E.M., Mendoza, S., Hamer, T. et al. (1994) Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metab. Clin. Exp., 43, 647\u2013654.","DOI":"10.1016\/0026-0495(94)90209-7"},{"key":"key\n\t\t\t\t20170410032420_VELAZQUEZ-ETAL-1997A","doi-asserted-by":"crossref","unstructured":"Velazquez, E.M., Mendoza, S.G., Wang, P. et al. (1997a) Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metab. Clin. Exp., 46, 454\u2013457.","DOI":"10.1016\/S0026-0495(97)90066-4"},{"key":"key\n\t\t\t\t20170410032420_VELAZQUEZ-ETAL-1997B","doi-asserted-by":"crossref","unstructured":"Velazquez, E.M., Acosta, A. and Mendoza, S.G. (1997b) Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet. Gynecol., 90, 392\u2013395.","DOI":"10.1016\/S0029-7844(97)00296-2"},{"key":"key\n\t\t\t\t20170410032420_WILLIS-AND-FRANKS-1995","doi-asserted-by":"crossref","unstructured":"Willis, D. and Franks, S. (1995) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J. Clin. Endocrinol. Metab., 80, 3788\u20133790.","DOI":"10.1210\/jcem.80.12.8530637"},{"key":"key\n\t\t\t\t20170410032420_WILLIS-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Willis, D., Mason, H., Gilling-Smith, C. et al. (1996) Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J. Clin. Endocrinol. Metab., 81, 302\u2013309.","DOI":"10.1210\/jc.81.1.302"},{"key":"key\n\t\t\t\t20170410032420_YEN-ETAL-1970","doi-asserted-by":"crossref","unstructured":"Yen, S.S., Vela, P., and Rankin, J. (1970) Inappropriate secretion of follicle stimulating hormone and luteinizing hormone in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 30, 435\u2013442.","DOI":"10.1210\/jcem-30-4-435"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T07:10:47Z","timestamp":1497510647000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/14.12.2963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[1999,12]]},"published-print":{"date-parts":[[1999,12]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/14.12.2963","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}